Comments
Dr Reddy’s Laboratories on Friday said the US Food and Drug Administration has issued a Form 483 with four observations after inspecting its active pharmaceutical ingredients facility in Medak, Telangana. Last week also, the company said that the USFDA had issued Form 483 with five observations. The company informed the exchanges that it will address the issues comprehensively within the stipulated time. Investors will closely monitor the development.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.